The PVD-B65 risk assessment tool was developed through analysis of multiple prognostic factors related to age as well as to both underlying lung disease and PH severity, namely pulmonary fibrosis without emphysema, elevated PVR, decreased 6MWD, and elevated BNP. Here, NPPB is linked to lung disorder.